• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Log in to your Inderes Free account to see all free content on this page.
Create account

Photocure

Less than 1K followers

PHO

Oslo Børs

Biotechnology & Pharmaceuticals

Health Care

Overview
Ownership
Investor consensus

Photocure is a medical technology company. The company specializes in photodynamic technology solutions. The solutions are used to treat diseases that cause bladder cancer and HPV. The main markets are dermatology and oncology, where the products are used by hospitals and research institutes worldwide. The company was founded in 1993 and is headquartered in Oslo, Norway.

Read more
Market cap
-
Turnover
-
Revenue
EBIT %
P/E
Dividend yield-%
Financial calendar
26.6.
2026

General meeting '26

29.7.
2026

Interim report Q2'26

28.10.
2026

Interim report Q3'26

All
Press releases
ShowingAll content types

Regulatory press release6/8/2026, 4:09 PM

PHO: Photocure and Artera to partner on digital pathology AI test evaluation for Bladder Cancer

Photocure
Press release6/8/2026, 4:08 PM

Photocure and Artera to partner on digital pathology AI test evaluation for Bladder Cancer

Photocure
Regulatory press release6/5/2026, 12:56 PM

Photocure ASA - Notice of the Annual General Meeting 26 June 2026

Photocure

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Regulatory press release6/5/2026, 12:56 PM

Photocure ASA - Notice of the Annual General Meeting 26 June 2026

Photocure
Regulatory press release6/4/2026, 2:37 PM

PHO: Financial calendar

Photocure
Regulatory press release6/4/2026, 2:30 PM

PHO: Photocure ASA to Acquire Vesica Health Inc., Strengthening Leadership in Bladder Cancer Diagnostics

Photocure
Regulatory press release6/4/2026, 2:30 PM

Photocure ASA to Acquire Vesica Health Inc., Strengthening Leadership in Bladder Cancer Diagnostics

Photocure
Regulatory press release5/18/2026, 3:00 PM

AUA 2026: new studies demonstrated Blue Light Cystoscopy benefits in high-risk NMIBC management and cost comparison study

Photocure
Press release5/18/2026, 3:00 PM

AUA 2026: new studies demonstrated Blue Light Cystoscopy benefits in high-risk NMIBC management and cost comparison study

Photocure
Regulatory press release5/7/2026, 5:00 AM

Photocure ASA: Results for the first quarter of 2026

Photocure
Regulatory press release5/7/2026, 5:00 AM

Photocure ASA: Results for the first quarter of 2026

Photocure
Regulatory press release5/4/2026, 6:00 AM

New health economic methodology published: comparing cost-effectiveness of BLC versus NBI imaging technology in bladder cancer

Photocure
Press release5/4/2026, 6:00 AM

Photocure: New health economic methodology published: comparing cost-effectiveness of BLC versus NBI imaging technology in bladder cancer

Photocure
Regulatory press release4/30/2026, 7:00 AM

Photocure ASA: Invitation to presentation of first quarter 2026 financial results

Photocure
Press release4/30/2026, 7:00 AM

Photocure ASA: Invitation to presentation of first quarter 2026 financial results

Photocure
Regulatory press release4/27/2026, 7:00 AM

Photocure ASA: Annual Report 2025

Photocure
Regulatory press release4/27/2026, 7:00 AM

Photocure ASA: Annual Report 2025

Photocure
Regulatory press release4/20/2026, 2:31 PM

Photocure ASA: Update on milestone payments from Asieris Pharmaceuticals

Photocure
Regulatory press release4/20/2026, 2:31 PM

Photocure ASA: Update on milestone payments from Asieris Pharmaceuticals

Photocure
Regulatory press release4/13/2026, 2:20 PM

PHO: Financial calendar

Photocure